REGENXBIO Inc. Class Action Lawsuit
Company: REGENXBIO Inc.
Ticker: (NASDAQ) RGNX
Class Action Period: February 9, 2022 - January 27, 2026
See If You Qualify For Monetary Reward
Join the REGENXBIO Inc. Class Action Lawsuit
CLASS ACTION PERIOD
February 9, 2022 - January 27, 2026
Allegations
According to the complaint, defendants provided investors with material information concerning REGENXBIO’s plan to develop and commercialize its product candidate RGX-111, a one-time gene therapy for the treatment of severe Mucopolysaccharidosis Type I, also known as Hurler syndrome. Defendants’ statements included, among other things, REGENXBIO’s positive assertions of RGX-111’s future trial success based on continuing positive biomarker and safety data from the ongoing PhaseI/II study. 3. Defendants provided these overwhelmingly positive statements to investors while, at the same time, disseminating false and misleading statements and/or concealing material adverse facts concerning the efficacy and safety of its RGX-111 trial study. On January 28, 2026, REGENXBIO issued a press release announcing that the FDA placed a clinical hold on its investigational gene therapy RGX-111. Defendants announced that an intraventricular CNS tumor was found in a participant treated in its RGX-111 Phase I/II study. Following this news, the price of REGENXBIO’s common stock declined from a closing market price of $13.41 per share on January 27, 2026, REGENXBIO’s stock price fell to $11.01 per share on January 28, 2026, a decline of 17.8% in the span of just a single day.
Eligibility
To join the lawsuit, you must have experienced a loss on REGENXBIO shares purchased within the class period specified above.
Lead Plaintiff Deadline
If you suffered a loss in REGENXBIO Inc. during the relevant time frame, you have until April 14, 2026 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
EXPLORE MORE CASES
Ultragenyx Pharmaceutical Inc.
RARE
Lead Plaintiff Deadline: April 6, 2026
Class Period: August 3, 2023 - December 26, 2025
Richtech Robotics Inc.
RR
Lead Plaintiff Deadline: April 3, 2026
Class Period: January 27, 2026 - January 29, 2026